Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Liang Wang, Tianmin Xu & Manhua Cui. (2018) Are ovarian cancer stem cells the target for innovative immunotherapy?. OncoTargets and Therapy 11, pages 2615-2626.
Read now
Read now
Muhammad Saif, E. I. Ager, Penelope Field & K. J. Lilischkis. (2018) The role of cancer stem cells and the therapeutic potential of TRX-E-002-1 in ovarian cancer. Expert Opinion on Orphan Drugs 6:8, pages 465-475.
Read now
Read now
Articles from other publishers (17)
Aleksandra Englisz, Marta Smycz-Kubańska & Aleksandra Mielczarek-Palacz. (2023) Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer. Diagnostics 13:10, pages 1714.
Crossref
Crossref
Polina V. Shnaider, Irina Yu. Petrushanko, Olga I. Aleshikova, Nataliya A. Babaeva, Lev A. Ashrafyan, Ekaterina I. Borovkova, Julia E. Dobrokhotova, Ivan M. Borovkov, Victoria O. Shender & Elena Khomyakova. (2023) Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Sarath S. Joseph, Dan H. V. Tran, Farhadul Islam & Vinod Gopalan. 2023. Current Cancer Biomarkers. Current Cancer Biomarkers
148
179
.
Patrycja Królewska‑Daszczyńska, Dominika Wendlocha, Marta Smycz‑Kubańska, Sebastian Stępień & Aleksandra Mielczarek‑palacz. (2022) Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review). Oncology Letters 24:6.
Crossref
Crossref
Ruhui Yang, Bingjin Liu, Mingyue Yang, Feng Xu, Songquan Wu & Shufang Zhao. (2022) Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation. Frontiers in Oncology 12.
Crossref
Crossref
Jin‐Ock Kim, Kwang‐Hyeok Kim, Eun Ji Baek, Bomi Park, Min Kyung So, Byoung Joon Ko, Han‐Jik Ko & Sang Gyu Park. (2021) A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors. Molecular Oncology 16:6, pages 1290-1308.
Crossref
Crossref
Ke Zhang, Hanyue Ying, Ruping Zhao, Yuanyuan Chen & Qinghua Deng. (2022) Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway. Chinese Herbal Medicines 14:1, pages 111-116.
Crossref
Crossref
Min Chen, Juan Su, Chunmei Feng, Ying Liu, Li Zhao & Yongjie Tian. (2021)
Chemokine CCL20 promotes the paclitaxel resistance of CD44
+
CD117
+
cells via the Notch1 signaling pathway in ovarian cancer
. Molecular Medicine Reports 24:3.
Crossref
Crossref
Wookyeom Yang, Dasol Kim, Dae Kyoung Kim, Kyung Un Choi, Dong Soo Suh & Jae Ho Kim. (2021) Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 22:10, pages 5059.
Crossref
Crossref
Ying Su, Ru Chen, Zhongcheng Han, Rong Xu, Lili Ma, Reyina Wufuli, Hongbo Liu, Fang Wang, Lei Ma, Rui Chen & Jiang Liu. (2021) Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis. Pathobiology 88:4, pages 267-276.
Crossref
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
307
339
.
S.O. Gening & I.I. Antoneeva. (2020) ROLE OF CANCER STEM CELLS IN OVARIAN CARCINOGENESIS. Ulyanovsk Medico-biological Journal:3, pages 82-103.
Crossref
Crossref
Paola Mattiolo, Seung-Mo Hong, Gaetano Paolino, Borislav C. Rusev, Giovanni Marchegiani, Roberto Salvia, Stefano Andrianello, Paola Capelli, Paola Piccoli, Claudia Parolini, Aldo Scarpa, Rita T. Lawlor & Claudio Luchini. (2020) CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype. International Journal of Molecular Sciences 21:16, pages 5794.
Crossref
Crossref
Karen Hoffmann, Hilmar Berger, Hagen Kulbe, Sukanija Thillainadarasan, Hans‐Joachim Mollenkopf, Tomasz Zemojtel, Eliane Taube, Silvia Darb‐Esfahani, Mandy Mangler, Jalid Sehouli, Radoslav Chekerov, Elena I Braicu, Thomas F Meyer & Mirjana Kessler. (2020) Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment. The EMBO Journal 39:6.
Crossref
Crossref
Rossella Farra, Matea Maruna, Francesca Perrone, Mario Grassi, Fabio Benedetti, Marianna Maddaloni, Maguie El Boustani, Salvo Parisi, Flavio Rizzolio, Giancarlo Forte, Fabrizio Zanconati, Maja Cemazar, Urska Kamensek, Barbara Dapas & Gabriele Grassi. (2019) Strategies for Delivery of siRNAs to Ovarian Cancer Cells. Pharmaceutics 11:10, pages 547.
Crossref
Crossref
Xingyue Zong & Kenneth P. Nephew. (2019) Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting. Cancers 11:7, pages 934.
Crossref
Crossref
Ugo Testa, Eleonora Petrucci, Luca Pasquini, Germana Castelli & Elvira Pelosi. (2018) Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines 5:1, pages 16.
Crossref
Crossref